Catalyst- and Reagent-Guided Selective Alkyl C-H Bond Functionalization

催化剂和试剂引导的选择性烷基 C-H 键官能化

基本信息

项目摘要

PROJECT SUMMARY Identifying just one new clinical candidate for the treatment of human disease usually requires the design, synthesis, testing, and redesign of thousands upon thousands of organic compounds. Improvements to synthetic technologies therefore have a major impact on the time required to identify clinical candidates by maximizing the number of compounds that can be accessed from a single precursor. In particular, adjusting key properties such as bioactivity, solubility, metabolism, and stability are best accomplished by methods that are capable of preparing a wide variety of new compounds with a minimal number of steps. Late-stage functionalization of carbon-hydrogen bonds offers medicinal chemists this coveted opportunity by facilitating the introduction of numerous types of functional groups into a given lead structure. Recent efforts have demonstrated that transition- metal catalysts can enable the diverse functionalization of strong alkyl C–H bonds within organic compounds via the intermediacy of an organoboron compound. However, methods to achieve control over the site- and stereoselectivity of alkyl C–H bond functionalization are limited by their strength and ubiquity in complex molecules. The proposed research focuses on the development of a broadly applicable strategy to achieve selectivity in the functionalization of C(sp3)–H bonds that is independent of inherent substrate preferences. The impact of this work is to enable practitioners to make precise structural edits to bioactive compounds without lengthy synthetic manipulation. The proposed approach converts a major challenge in complex molecule functionalization, the presence of potentially intervening groups, into an opportunity to localize reactivity of a transition metal catalyst to convert specific C–H bonds into C–B bonds. Specifically, the proposed research will create catalysts and reagents that bind an existing polar functional group, such an alcohol or amide, thereby guiding functionalization to an adjacent site. Synthetic routes are presented to access a suite of catalysts and reagents. In conjunction with experiments to evaluate their suitably for guided functionalization, they will be refined iteratively for application to target structures. Subsequent studies of the functionalization of complex, biologically active compounds will demonstrate the applicability and generality of the proposed method to lead optimization. To control stereoselectivity, a key consideration in alkyl C–H bond functionalization, chiral diborane reagents derived from readily available precursors will be employed. By differentiating the energies of diastereomeric intermediates and transition states en route to the alkylboronate products, new derivatives can be accessed with well-defined three-dimensional structures. An integrated component of the proposed research program are mechanistic experiments that will form the basis of informed improvements to the overall approach, as defined by metrics that include reaction efficiency, site-selectivity, and stereo-selectivity. Achieving the specific aims of the proposed research will expand the opportunities available to scientists to make precise edits to complex organic compounds at alkyl C–H bonds, facilitating access to new bioactive compounds.
PROJECT SUMMARY Identifying just one new clinical candidate for the treatment of human disease usually requires the design, synthesis, testing, and redesign of thousands upon thousands of organic compounds. Improvements to synthetic technologies therefore have a major impact on the time required to identify clinical candidates by maximizing the number of compounds that can be accessed from a single precursor. In particular, adjusting key properties such as bioactivity, solubility, metabolism, and stability are best accomplished by methods that are capable of preparing a wide variety of new compounds with a minimal number of steps. Late-stage functionalization of carbon-hydrogen bonds offers medicinal chemists this coveted opportunity by facilitating the introduction of numerous types of functional groups into a given lead structure. Recent efforts have demonstrated that transition- metal catalysts can enable the diverse functionalization of strong alkyl C–H bonds within organic compounds via the intermediacy of an organoboron compound. However, methods to achieve control over the site- and stereoselectivity of alkyl C–H bond functionalization are limited by their strength and ubiquity in complex molecules. The proposed research focuses on the development of a broadly applicable strategy to achieve selectivity in the functionalization of C(sp3)–H bonds that is independent of inherent substrate preferences. The impact of this work is to enable practitioners to make precise structural edits to bioactive compounds without lengthy synthetic manipulation. The proposed approach converts a major challenge in complex molecule functionalization, the presence of potentially intervening groups, into an opportunity to localize reactivity of a transition metal catalyst to convert specific C–H bonds into C–B bonds. Specifically, the proposed research will create catalysts and reagents that bind an existing polar functional group, such an alcohol or amide, thereby guiding functionalization to an adjacent site. Synthetic routes are presented to access a suite of catalysts and reagents. In conjunction with experiments to evaluate their suitably for guided functionalization, they will be refined iteratively for application to target structures. Subsequent studies of the functionalization of complex, biologically active compounds will demonstrate the applicability and generality of the proposed method to lead optimization. To control stereoselectivity, a key consideration in alkyl C–H bond functionalization, chiral diborane reagents derived from readily available precursors will be employed. By differentiating the energies of diastereomeric intermediates and transition states en route to the alkylboronate products, new derivatives can be accessed with well-defined three-dimensional structures. An integrated component of the proposed research program are mechanistic experiments that will form the basis of informed improvements to the overall approach, as defined by metrics that include reaction efficiency, site-selectivity, and stereo-selectivity. Achieving the specific aims of the proposed research will expand the opportunities available to scientists to make precise edits to complex organic compounds at alkyl C–H bonds, facilitating access to new bioactive compounds.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyan Anthony D'Angelo其他文献

Kyan Anthony D'Angelo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140205
  • 财政年份:
    2022
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140196
  • 财政年份:
    2022
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
  • 批准号:
    504378162
  • 财政年份:
    2022
  • 资助金额:
    $ 6.91万
  • 项目类别:
    WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
  • 批准号:
    22H02743
  • 财政年份:
    2022
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10532252
  • 财政年份:
    2021
  • 资助金额:
    $ 6.91万
  • 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
  • 批准号:
    2146728
  • 财政年份:
    2021
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10399712
  • 财政年份:
    2021
  • 资助金额:
    $ 6.91万
  • 项目类别:
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
  • 批准号:
    20K21285
  • 财政年份:
    2020
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
  • 批准号:
    558383-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Canadian Graduate Scholarships Foreign Study Supplements
Catalytic Synthesis of Pharmaceutical Amides in Water
水中催化合成药用酰胺
  • 批准号:
    EP/T01430X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了